Applied Therapeutics Inc logo

Applied Therapeutics Inc

NAS:APLT (USA)  
$ 5.14 -0.12 (-2.28%) 10:08 PM EST
At Loss
P/B:
8.73
Market Cap:
$ 587.33M
Enterprise V:
$ 441.19M
Volume:
512.83K
Avg Vol (2M):
1.17M
Trade In:
Volume:
512.83K
At Loss
Avg Vol (2M):
1.17M

Business Description

Description
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
Name Current Vs Industry Vs History
Cash-To-Debt 427.07
Equity-to-Asset 0.45
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.61
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 40.16
9-Day RSI 49.98
14-Day RSI 52.91
6-1 Month Momentum % 77.17
12-1 Month Momentum % 208.22

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.8
Quick Ratio 1.8
Cash Ratio 1.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -55.7
Shareholder Yield % -28.96

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % 15675.47
Net Margin % 40579.46
FCF Margin % 14065.83
ROE % -3152.71
ROA % -297.87
ROIC % -176.35
ROC (Joel Greenblatt) % -11510.47
ROCE % -1103.42

Financials (Next Earnings Date:2024-08-09 Est.)

APLT's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:APLT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Applied Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) -0.477
EPS (TTM) ($) -1.84
Beta 2.39
Volatility % 170.2
14-Day RSI 52.91
14-Day ATR ($) 0.353192
20-Day SMA ($) 4.944
12-1 Month Momentum % 208.22
52-Week Range ($) 1.18 - 9.39
Shares Outstanding (Mil) 114.27

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Applied Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Applied Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Applied Therapeutics Inc Frequently Asked Questions

What is Applied Therapeutics Inc(APLT)'s stock price today?
The current price of APLT is $5.14. The 52 week high of APLT is $9.39 and 52 week low is $1.18.
When is next earnings date of Applied Therapeutics Inc(APLT)?
The next earnings date of Applied Therapeutics Inc(APLT) is 2024-08-09 Est..
Does Applied Therapeutics Inc(APLT) pay dividends? If so, how much?
Applied Therapeutics Inc(APLT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1